{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:36:14Z","timestamp":1793658974802,"version":"4.5.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.bioorg.2025.108269","type":"journal-article","created":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T18:40:35Z","timestamp":1739644835000},"page":"108269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Design, synthesis and molecular modeling of new Pyrazolyl-Benzimidazolone hybrids targeting breast Cancer"],"prefix":"10.1016","volume":"157","author":[{"given":"Mohamed","family":"Adardour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al-Hassan M.","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Oubahmane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marouane Ait","family":"Lahcen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad M.","family":"Seif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal Abdel Fattah","family":"Ezzat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Zaballos-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel T.","family":"Mague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Hdoufane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Driss","family":"Cherqaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver H.","family":"Kr\u00e4mer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Sippl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hany S.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdesselam","family":"Baouid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108269_bb0005","doi-asserted-by":"crossref","DOI":"10.1177\/17588359211013326","article-title":"Recent advances in the treatment of hormone receptor-positive\/human epidermal growth factor 2-positive advanced breast cancer","volume":"13","author":"Lv","year":"2021","journal-title":"Therapeutic Advances in Medical Oncology"},{"key":"10.1016\/j.bioorg.2025.108269_bb0010","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/ijc.22892","article-title":"Prognostic effect of estrogen receptor status across age in primary breast cancer","volume":"122","author":"Bentzon","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bioorg.2025.108269_bb0015","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/654698","article-title":"Role of estrogen receptor signaling in breast Cancer metastasis","volume":"2012","author":"Saha Roy","year":"2012","journal-title":"Int J Breast Cancer"},{"key":"10.1016\/j.bioorg.2025.108269_bb0020","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejmech.2019.05.023","article-title":"Estrogen signaling: an emanating therapeutic target for breast cancer treatment","volume":"177","author":"Saha","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108269_bb0025","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11914-010-0025-0","article-title":"New selective estrogen receptor modulators (SERMs) in development","volume":"8","author":"Silverman","year":"2010","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.bioorg.2025.108269_bb0030","series-title":"Estrogen Receptor and Breast Cancer: Celebrating the 60th Anniversary of the Discovery of ER","first-page":"189","article-title":"A novel strategy to improve Women\u2019s health: Selective estrogen receptor modulators","author":"Abderrahman","year":"2019"},{"key":"10.1016\/j.bioorg.2025.108269_bb0035","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1124\/mol.111.072249","article-title":"The selective estrogen receptor modulator Bazedoxifene inhibits hormone-independent breast Cancer cell growth and Down-regulates estrogen receptor \u03b1 and cyclin D1","volume":"80","author":"Lewis-Wambi","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108269_bb0040","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1124\/mol.115.100925","article-title":"The dual estrogen receptor <em>\u03b1<\/em> inhibitory effects of the tissue-selective estrogen complex for endometrial and breast safety","volume":"89","author":"Han","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108269_bb0045","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.maturitas.2014.10.010","article-title":"Selective estrogen receptor modulators (SERMs): a review of clinical data","volume":"80","author":"Mirkin","year":"2015","journal-title":"Maturitas"},{"key":"10.1016\/j.bioorg.2025.108269_bb0050","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.ajpath.2017.12.011","article-title":"Long-term treatment of tamoxifen and Raloxifene alleviates dystrophic phenotype and enhances muscle functions of FKRP Dystroglycanopathy","volume":"188","author":"Wu","year":"2018","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bioorg.2025.108269_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105554","article-title":"Structure-based design and synthesis of conformationally constrained derivatives of methyl-piperidinopyrazole (MPP) with estrogen receptor (ER) antagonist activity","volume":"119","author":"Ragab","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108269_bb0060","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1021\/jm00351a010","article-title":"Estrogenic and antiestrogenic activity of monophenolic analogs of tamoxifen, [(Z)-2-[p-(1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine]","volume":"25","author":"Ruenitz","year":"1982","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108269_bb0065","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1021\/ol0062650","article-title":"Regioselective synthesis of 1,3,5-Triaryl-4-alkylpyrazoles: novel ligands for the estrogen receptor","volume":"2","author":"Huang","year":"2000","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2025.108269_bb0070","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1021\/jm000170m","article-title":"Pyrazole ligands: structure\u2212affinity\/activity relationships and estrogen receptor-\u03b1-selective agonists","volume":"43","author":"Stauffer","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108269_bb0075","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bmcl.2008.11.006","article-title":"Analogs of methyl-piperidinopyrazole (MPP): antiestrogens with estrogen receptor \u03b1 selective activity","volume":"19","author":"Zhou","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108269_bb0080","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.bbrc.2014.06.130","article-title":"Benzimidazoles diminish ERE transcriptional activity and cell growth in breast cancer cells","volume":"450","author":"Payton-Stewart","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioorg.2025.108269_bb0085","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejmech.2018.01.051","article-title":"Design, synthesis and biological evaluation of novel indole-benzimidazole hybrids targeting estrogen receptor alpha (ER-\u03b1)","volume":"146","author":"Singla","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108269_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103929","article-title":"Design, synthesis and anticancer\/antiestrogenic activities of novel indole-benzimidazoles","volume":"100","author":"Karadayi","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108269_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00044-013-0612-6","article-title":"Impact of ABC transporters, glutathione conjugates in MDR and their modulation by flavonoids: an overview","volume":"23","author":"Gupta","year":"2014","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2025.108269_bb0100","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.3390\/molecules27165245","article-title":"New Benzimidazoles targeting breast Cancer: synthesis, Pin1 inhibition, 2D NMR binding, and computational studies","volume":"27","author":"Nashaat","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.108269_bb0105","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.molstruc.2018.03.128","article-title":"Synthesis, characterization and X-ray structure of heterocyclic systems prepared via 1,3-dipolar cycloaddition of nitrile oxides with benzimidazolone","volume":"1165","author":"Adardour","year":"2018","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.108269_bb0110","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1080\/00397911.2020.1803913","article-title":"Efficient and simple synthesis of novel 1,2,3-triazolyl-linked benzimidazolone, molecular docking and evaluation of their antimicrobial activity","volume":"50","author":"Adardour","year":"2020","journal-title":"Synth. Commun."},{"key":"10.1016\/j.bioorg.2025.108269_bb0115","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.3390\/ph16121648","article-title":"Design, synthesis, molecular modeling and biological evaluation of novel Pyrazole Benzimidazolone derivatives as potent antioxidants","volume":"16","author":"Adardour","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2025.108269_bb0120","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.3390\/ph16121648","article-title":"Molecular modeling and biological evaluation of novel Pyrazole Benzimidazolone derivatives as potent antioxidants","volume":"16","author":"Adardour","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2025.108269_bb0125","doi-asserted-by":"crossref","first-page":"6923","DOI":"10.1039\/D2OB01253G","article-title":"Synthesis of 1,3,5-trisubstituted pyrazoles via 1,3-dipolar cycloaddition of nitrile imines with ninhydrin-derived Morita\u2013Baylis\u2013Hillman carbonates","volume":"20","author":"Wang","year":"2022","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2025.108269_bb0130","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1021\/acs.accounts.5b00075","article-title":"Cycloadditions in modern polymer chemistry","volume":"48","author":"Delaittre","year":"2015","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.bioorg.2025.108269_bb0135","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1038\/onc.2012.515","article-title":"SIAH ubiquitin ligases target the nonreceptor tyrosine kinase ACK1 for ubiquitinylation and proteasomal degradation","volume":"32","author":"Buchwald","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2025.108269_bb0140","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/sj.onc.1210677","article-title":"Histone deacetylase inhibitors and hydroxyurea modulate the cell cycle and cooperatively induce apoptosis","volume":"27","author":"Kr\u00e4mer","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2025.108269_bb0145","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41523-022-00397-y","article-title":"Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models","volume":"8","author":"Michmerhuizen","year":"2022","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.bioorg.2025.108269_bb0150","first-page":"1","article-title":"Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models","volume":"8","author":"Michmerhuizen","year":"2022","journal-title":"Npj Breast Cancer"},{"key":"10.1016\/j.bioorg.2025.108269_bb0155","series-title":"SAINT a Program for Integration of Raw X-Ray Diffraction Intensities","year":"2021"},{"key":"10.1016\/j.bioorg.2025.108269_bb0160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S1600576714022985","article-title":"Comparison of silver and molybdenum microfocus X-ray sources for single-crystal structure determination","volume":"48","author":"Krause","year":"2015","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.bioorg.2025.108269_bb0165","doi-asserted-by":"crossref","first-page":"C1437","DOI":"10.1107\/S2053273314085623","article-title":"SHELXT: integrating space group determination and structure solution","volume":"70","author":"Sheldrick","year":"2014","journal-title":"Acta Crystallogr. A"},{"key":"10.1016\/j.bioorg.2025.108269_bb0170","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053229614024218","article-title":"Crystal structure refinement with SHELXL","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr. C"},{"key":"10.1016\/j.bioorg.2025.108269_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114661","article-title":"New thiazole-based derivatives as EGFR\/HER2 and DHFR inhibitors: synthesis, molecular modeling simulations and anticancer activity","volume":"241","author":"Sabry","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108269_bb0180","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.bioorg.2018.07.015","article-title":"Dual EGFR\/HER2 inhibitors and apoptosis inducers: new benzo[g]quinazoline derivatives bearing benzenesulfonamide as anticancer and radiosensitizers","volume":"80","author":"Ghorab","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108269_bb0185","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.reprotox.2020.10.008","article-title":"The optimal compound reference genes for qRT-PCR analysis in the developing rat long bones under physiological conditions and prenatal dexamethasone exposure model","volume":"98","author":"Han","year":"2020","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.bioorg.2025.108269_bb0190","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3390\/ijms23010369","article-title":"Synthesis, molecular docking and biological characterization of pyrazine linked 2-Aminobenzamides as new class I selective histone deacetylase (HDAC) inhibitors with anti-leukemic activity","volume":"23","author":"Ibrahim","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108269_bb0195","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jare.2023.07.005","article-title":"Novel hydroxamic acid derivative induces apoptosis and constrains autophagy in leukemic cells","volume":"60","author":"Fischer","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.bioorg.2025.108269_bb0200","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1034\/j.1600-0463.2001.090503.x","article-title":"Tissue-specific expression pattern of estrogen receptors (ER): quantification of ER alpha and ER beta mRNA with real-time RT-PCR","volume":"109","author":"Pfaffl","year":"2001","journal-title":"APMIS"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108269_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-04413-3","article-title":"Specific stereochemistry of OP-1074 disrupts estrogen receptor alpha helix 12 and confers pure antiestrogenic activity","volume":"9","author":"Fanning","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2025.108269_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2024.105870","article-title":"Drug design of new anti-EBOV inhibitors: QSAR, homology modeling, molecular docking and molecular dynamics studies","volume":"17","author":"Ait Lahcen","year":"2024","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.bioorg.2025.108269_bb0215","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.3390\/ph16121648","article-title":"Design, Synthesis, Molecular Modeling and Biological Evaluation of Novel Pyrazole Benzimidazolone Derivatives as Potent Antioxidants","volume":"16","author":"Adardour","year":"2023","journal-title":"Pharmaceuticals (Basel)"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682500149X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682500149X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T21:36:41Z","timestamp":1763847401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004520682500149X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":43,"alternative-id":["S004520682500149X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108269","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and molecular modeling of new Pyrazolyl-Benzimidazolone hybrids targeting breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108269","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108269"}}